Skip to content

Navigation With X3 vs Non-Navigation With X3 Study

Comparison X3 Study Between Navi-THA and Non-navi-THA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02543463
Enrollment
49
Registered
2015-09-07
Start date
2015-04-30
Completion date
2017-07-31
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Joint Disease

Brief summary

The purpose of this study is to compare the effect of the large head in THA with a navigation system and without a navigation system.

Interventions

DEVICETrident X3 Insert with Navigation system
DEVICETrident X3 Insert with conventional instrumentation

Sponsors

Stryker Japan K.K.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient who is a candidate for a primary total hip arthroplasty (THA) with cementless acetabular and femoral components. 2. Patient who has a diagnosis of degenerative joint disease and no bacterial infectious disease. 3. Patient who is age 20 or over. 4. Patient who signed an Institutional Review Board (IRB)-approved, study specific Informed Patient Consent Form. 5. Patient who is willing to and able to comply with postoperative scheduled evaluations.

Exclusion criteria

1. Patient who has a bacterial infectious disease or has a high risk of a bacterial infection. 2. Patient who requires revision surgery of a previously implanted total hip arthroplasty. 3. Patient who is morbidly obese, defined as having a Body Mass Index (BMI) \> 45. 4. Patient who is or may be pregnant female. 5. Patient who has neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device. 6. Patient with diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy). 7. Patient who is immunologically suppressed or receiving chronic steroids. 8. Patient who is judged ineligible with specific reason by primary doctor.

Design outcomes

Primary

MeasureTime frame
Range of motion (ROM) during surgeryintraoperative

Secondary

MeasureTime frameDescription
Measuring accuracy of the ROM during surgeryIntraoperativeMeasurement ROM precision of intraoperative
implantation accuracyIntraoperativeMeasurement of the degree of stem anteversion, cup anteversion and cup abduction
Postoperative dislocationFrom intraoperative to 1yr

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026